Abstract:BACKGROUND:Genome-wide association studies (GWAS) have successfully identified genetic susceptible variants for complex diseases. However, the underlying mechanism of such association remains largely unknown. Most disease-associated genetic variants have been shown to reside in noncoding regions, leading to the hypothesis that regulation of gene expression may be the primary biological mechanism. Current methods to characterize gene expression mediating the effect of genetic variant on diseases, often analyzed one gene at a time and ignored the network structure. The impact of genetic variant can propagate to other genes along the links in the network, then to the final disease. There could be multiple pathways from the genetic variant to the final disease, with each having the chain structure since the first node is one specific SNP (Single Nucleotide Polymorphism) variant and the end is disease outcome. One key but inadequately addressed question is how to measure the between-node connection strength and rank the effects of such chain-type pathways, which can provide statistical evidence to give the priority of some pathways for potential drug development in a cost-effective manner.RESULTS:We first introduce the maximal correlation coefficient (MCC) to represent the between-node connection, and then integrate MCC with K shortest paths algorithm to rank and identify the potential pathways from genetic variant to disease. The pathway importance score (PIS) was further provided to quantify the importance of each pathway. We termed this method as "MCC-SP". Various simulations are conducted to illustrate MCC is a better measurement of the between-node connection strength than other quantities including Pearson correlation, Spearman correlation, distance correlation, mutual information, and maximal information coefficient. Finally, we applied MCC-SP to analyze one real dataset from the Religious Orders Study and the Memory and Aging Project, and successfully detected 2 typical pathways from APOE genotype to Alzheimer's disease (AD) through gene expression enriched in Alzheimer's disease pathway.CONCLUSIONS:MCC-SP has powerful and robust performance in identifying the pathway(s) from the genetic variant to the disease. The source code of MCC-SP is freely available at GitHub ( https://github.com/zhuyuchen95/ADnet ).

Identifying Disease Related Sub-Pathways for Analysis of Genome-Wide Association Studies

MCC-SP: a Powerful Integration Method for Identification of Causal Pathways from Genetic Variants to Complex Disease.

Pathway Analysis of Complex Diseases for GWAS, Extending to Consider Rare Variants, Multi-Omics and Interactions

Improving the detection of pathways in genome-wide association studies by combined effects of SNPs from Linkage Disequilibrium blocks

Gene and Pathway-Based Analysis: Second Wave of Genome-wide Association Studies

Genome-wide interaction-based association analysis identified multiple new susceptibility Loci for common diseases.

Gene and Pathway-Based Second-Wave Analysis of Genome-Wide Association Studies

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

Integrated analysis of variants and pathways in genome-wide association studies using polygenic models of disease

Towards Constructing Disease Relationship Networks Using Genome-Wide Association Studies

Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways.

A comprehensive framework for trans-ancestry pathway analysis using GWAS summary data from diverse populations

Icsnpathway: Identify Candidate Causal Snps And Pathways From Genome-Wide Association Study By One Analytical Framework

Identifying Disease Associations Via Genome-Wide Association Studies

The implications of relationships between human diseases and metabolic subpathways

Strategies for Pathway Analysis from GWAS Data

Identification of susceptible genes for complex chronic diseases based on disease risk functional SNPs and interaction networks

Integrating Embeddings of Multiple Gene Networks to Prioritize Complex Disease-Associated Genes

Pathways-Driven Sparse Regression Identifies Pathways and Genes Associated with High-Density Lipoprotein Cholesterol in Two Asian Cohorts

Complex-disease networks of trait-associated single-nucleotide polymorphisms (SNPs) unveiled by information theory

Searching Genome-Wide Multi-Locus Associations for Multiple Diseases Based on Bayesian Inference.